Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Telotristat ethyl: a new option for the management of carcinoid syndrome
Ángela Lamarca, Jorge Barriuso, Mairéad G. McNamara, et al.
Expert Opinion on Pharmacotherapy (2016) Vol. 17, Iss. 18, pp. 2487-2498
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Prodrugs as empowering tools in drug discovery and development: recent strategic applications of drug delivery solutions to mitigate challenges associated with lead compounds and drug candidates
Murugaiah A. M. Subbaiah, Jarkko Rautio, Nicholas A. Meanwell
Chemical Society Reviews (2024) Vol. 53, Iss. 4, pp. 2099-2210
Closed Access | Times Cited: 27
Carcinoid-syndrome: recent advances, current status and controversies
Tetsuhide Ito, Lingaku Lee, Robert T. Jensen
Current Opinion in Endocrinology Diabetes and Obesity (2017) Vol. 25, Iss. 1, pp. 22-35
Open Access | Times Cited: 118
Peripheral Serotonin Synthesis as a New Drug Target
Susann Matthes, Michael Bäder
Trends in Pharmacological Sciences (2018) Vol. 39, Iss. 6, pp. 560-572
Closed Access | Times Cited: 89
Pyrazole-containing pharmaceuticals: target, pharmacological activity, and their SAR studies
Guangchen Li, Yifu Cheng, Chi Han, et al.
RSC Medicinal Chemistry (2022) Vol. 13, Iss. 11, pp. 1300-1321
Open Access | Times Cited: 61
Intestinal secretory mechanisms and diarrhea
Stephen J. Keely, Kim E. Barrett
AJP Gastrointestinal and Liver Physiology (2022) Vol. 322, Iss. 4, pp. G405-G420
Open Access | Times Cited: 48
Fluorine in the pharmaceutical industry: Synthetic approaches and application of clinically approved fluorine-enriched anti-infectious medications
Zhen-Xi Niu, Jing Hu, Jinfeng Sun, et al.
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116446-116446
Closed Access | Times Cited: 9
Mesenteric Fibrosis in Neuroendocrine Neoplasms: a Systematic Review of New Thoughts on Causation and Potential Treatments
Ariadni Spyroglou, Odysseas Violetis, Konstantinos Iliakopoulos, et al.
Current Oncology Reports (2025)
Open Access | Times Cited: 1
Advanced neuroendocrine tumours of the small intestine and pancreas: clinical developments, controversies, and future strategies
Christoph J. Auernhammer, Christine Spitzweg, Martin K. Angele, et al.
The Lancet Diabetes & Endocrinology (2017) Vol. 6, Iss. 5, pp. 404-415
Closed Access | Times Cited: 66
Inhibition of serotonin synthesis: A novel therapeutic paradigm
Michael Bäder
Pharmacology & Therapeutics (2019) Vol. 205, pp. 107423-107423
Closed Access | Times Cited: 61
Somatostatin analogue-induced pancreatic exocrine insufficiency in patients with neuroendocrine tumors: results of a prospective observational study
Ángela Lamarca, Lynne McCallum, Christina Nuttall, et al.
Expert Review of Gastroenterology & Hepatology (2018) Vol. 12, Iss. 7, pp. 723-731
Open Access | Times Cited: 49
Lung Carcinoids: A Comprehensive Review for Clinicians
Donald Granberg, C. Christofer Juhlin, Henrik Falhammar, et al.
Cancers (2023) Vol. 15, Iss. 22, pp. 5440-5440
Open Access | Times Cited: 16
Updates on the biology of serotonin and tryptophan hydroxylase
Tara Swami, H. Christian Weber
Current Opinion in Endocrinology Diabetes and Obesity (2017) Vol. 25, Iss. 1, pp. 12-21
Closed Access | Times Cited: 41
Gastrointestinal neuroendocrine tumor syndromes (GI-NETS)
Tetsuhide Ito, Robert T. Jensen
Elsevier eBooks (2025)
Closed Access
Supportive therapy in gastroenteropancreatic neuroendocrine tumors: Often forgotten but important
Xi‐Feng Jin, Matilde Pia Spampatti, Christine Spitzweg, et al.
Reviews in Endocrine and Metabolic Disorders (2018) Vol. 19, Iss. 2, pp. 145-158
Closed Access | Times Cited: 30
Successes, failures, and future prospects of prodrugs and their clinical impact
Anas Najjar, Rafik Karaman
Expert Opinion on Drug Discovery (2019) Vol. 14, Iss. 3, pp. 199-220
Closed Access | Times Cited: 24
Perspectives on the current pharmacotherapeutic strategies for management of functional neuroendocrine tumor syndromes
Tetsuhide Ito, Robert T. Jensen
Expert Opinion on Pharmacotherapy (2020) Vol. 22, Iss. 6, pp. 685-693
Open Access | Times Cited: 22
Carcinoid Syndrome: Preclinical Models and Future Therapeutic Strategies
Giovanni Vitale, Silvia Carra, Ylenia Alessi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3610-3610
Open Access | Times Cited: 8
Medical Therapy of Gastrointestinal Neuroendocrine Tumors
Kjell Öberg
Visceral Medicine (2017) Vol. 33, Iss. 5, pp. 352-356
Open Access | Times Cited: 19
New and emerging systemic therapy options for well-differentiated gastroenteropancreatic neuroendocrine tumors
Steven D. Scoville, Jordan M. Cloyd, Timothy M. Pawlik
Expert Opinion on Pharmacotherapy (2019) Vol. 21, Iss. 2, pp. 183-191
Closed Access | Times Cited: 14
Polyfluorinated scaffolds in drug discovery
Fabrizio Pertusati, Michaela Serpi, Elisa Pileggi
Elsevier eBooks (2018), pp. 141-180
Closed Access | Times Cited: 13
The emerging role of targeted therapies for advanced well-differentiated gastroenteropancreatic neuroendocrine tumors
Jordan M. Cloyd, Bhavana Konda, Manisha H. Shah, et al.
Expert Review of Clinical Pharmacology (2018) Vol. 12, Iss. 2, pp. 101-108
Closed Access | Times Cited: 13
Assessment of Peripheral Serotonin Synthesis Using Stable Isotope‐Labeled Tryptophan
Martine Géhin, Richard W.D. Welford, Marco Garzotti, et al.
Clinical Pharmacology & Therapeutics (2018) Vol. 104, Iss. 6, pp. 1260-1267
Closed Access | Times Cited: 10
Efficacy of Detoxsan®powder on diarrhea caused by gastrointestinal neuroendocrine tumors
Thomas Langbein, W. Dathe, Anika Deuerling, et al.
World Journal of Gastroenterology (2019) Vol. 25, Iss. 17, pp. 2133-2143
Open Access | Times Cited: 7
Practical management of toxicities associated with targeted therapies for advanced gastroenteropancreatic neuroendocrine tumors
Pieter‐Jan Cuyle
Annals of Gastroenterology (2018)
Open Access | Times Cited: 6
<p>Spotlight on telotristat ethyl for the treatment of carcinoid syndrome diarrhea: patient selection and reported outcomes</p>
Cristina Saavedra, Jorge Barriuso, Mairéad G. McNamara, et al.
Cancer Management and Research (2019) Vol. Volume 11, pp. 7537-7556
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top